France Refines Early Access System Again
Significant Benefits Seen For Patients With No Other Options
Following last year’s reform of the scheme that allows early access to unapproved or non-reimbursed medicines, the rules are being changed again, including the criteria used to determine whether an “appropriate treatment” is already available.
